159 related articles for article (PubMed ID: 21224744)
1. Beware of the focal uptake at the ischium on the bone scan in prostate cancer.
Hassan FU; Mohan HK; Gnanasegaran G; Vijayanathan S; Fogelman I
Nucl Med Commun; 2011 Apr; 32(4):320-3. PubMed ID: 21224744
[TBL] [Abstract][Full Text] [Related]
2. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
3. The improved accuracy of planar bone scintigraphy by adding single photon emission computed tomography (SPECT-CT) to detect skeletal metastases from prostate cancer.
McLoughlin LC; O'Kelly F; O'Brien C; Sheikh M; Feeney J; Torreggiani W; Thornhill JA
Ir J Med Sci; 2016 Feb; 185(1):101-5. PubMed ID: 25394725
[TBL] [Abstract][Full Text] [Related]
4. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of Accuracy of Planar and Evolution SPECT/CT Bone Imaging in Differentiating Benign from Metastatic Bone Lesions.
Teyateeti A; Tocharoenchai C; Muangsomboon K; Komoltri C; Pusuwan P
J Med Assoc Thai; 2017 Jan; 100(1):100-10. PubMed ID: 29911774
[TBL] [Abstract][Full Text] [Related]
6. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
7. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
[TBL] [Abstract][Full Text] [Related]
8. The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate.
Helyar V; Mohan HK; Barwick T; Livieratos L; Gnanasegaran G; Clarke SE; Fogelman I
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):706-13. PubMed ID: 20016889
[TBL] [Abstract][Full Text] [Related]
9. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management.
Hetzel M; Arslandemir C; König HH; Buck AK; Nüssle K; Glatting G; Gabelmann A; Hetzel J; Hombach V; Schirrmeister H
J Bone Miner Res; 2003 Dec; 18(12):2206-14. PubMed ID: 14672356
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
Nakamoto Y; Osman M; Wahl RL
Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions.
Zhang Y; Shi H; Gu Y; Xiu Y; Li B; Zhu W; Chen S; Yu H
Nucl Med Commun; 2011 Dec; 32(12):1194-200. PubMed ID: 21934544
[TBL] [Abstract][Full Text] [Related]
12. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
[TBL] [Abstract][Full Text] [Related]
13. Study on the distribution features of bone metastases in prostate cancer.
Wang C; Shen Y
Nucl Med Commun; 2012 Apr; 33(4):379-83. PubMed ID: 22293499
[TBL] [Abstract][Full Text] [Related]
14. Nuclear Medicine Imaging Techniques for Detection of Skeletal Metastases in Breast Cancer.
Iagaru A; Minamimoto R
PET Clin; 2018 Jul; 13(3):383-393. PubMed ID: 30100077
[TBL] [Abstract][Full Text] [Related]
15. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.
Grewal RK; Tuttle RM; Fox J; Borkar S; Chou JF; Gonen M; Strauss HW; Larson SM; Schöder H
J Nucl Med; 2010 Sep; 51(9):1361-7. PubMed ID: 20720058
[TBL] [Abstract][Full Text] [Related]
16. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
Horger M; Bares R
Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer: role of SPECT and PET in imaging bone metastases.
Beheshti M; Langsteger W; Fogelman I
Semin Nucl Med; 2009 Nov; 39(6):396-407. PubMed ID: 19801219
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography and bone metastases.
Fogelman I; Cook G; Israel O; Van der Wall H
Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
[TBL] [Abstract][Full Text] [Related]
19. SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients.
Römer W; Nömayr A; Uder M; Bautz W; Kuwert T
J Nucl Med; 2006 Jul; 47(7):1102-6. PubMed ID: 16818944
[TBL] [Abstract][Full Text] [Related]
20. The added value of SPECT/spiral CT in patients with equivocal bony metastasis from hepatocellular carcinoma.
Zhang Y; Shi H; Li B; Cai L; Gu Y; Xiu Y
Nuklearmedizin; 2015; 54(6):255-61. PubMed ID: 26615876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
